Through consultation with key audiences involved in osteoporosis and bone health the National Osteoporosis Society has identified priority areas for research.
Burden of disease
- Characterisation of the prevalence and incidence of fragility fractures in the UK (including socioeconomic, age and gender variations)
- Understanding the burden and impact that fragility fractures are having on individuals and the community
Current/Novel treatment and patient care
- Optimal pain management
- Long-term effects of bisphosphonates (bone quality, adverse effects)
- Use of vitamin D in prevention and therapy of bone loss
- Optimal duration of treatment with bisphosphonates
Diagnosis and Risk Assessment
- Ensuring new and existing techniques are utilised effectively, and to their full potential to assist diagnosis and treatment.
- Use of FRAX and QFracture in primary care to identify people at risk of fracture, and in adults living in residential care
Mechanisms of disease
- Understanding the mechanisms of pain from fragility fractures (especially vertebral fractures)
- Understanding the pathogenesis of secondary causes of osteoporosis in order to improve diagnosis and target treatment
Please note that this list is not prescriptive, but highlights areas where the Charity feels research should be encouraged. For further information see the Charity’s Research Strategy 2011-2014.